Sarkis Meterissian
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Sarkis Meterissian"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Parvez E, Martel K, Morency D, et al. (2020) Surgical and Oncologic Outcomes of Nipple-Sparing Mastectomy for a Cohort of Breast Cancer Patients, Including Cases with High-Risk Features. Clinical Breast Cancer |
| Lagacé F, Ghazawi FM, Le M, et al. (2019) Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada. Breast Cancer Research and Treatment |
| Sabiston CM, Fong AJ, O'Loughlin EK, et al. (2019) A mixed-methods evaluation of a community physical activity program for breast cancer survivors. Journal of Translational Medicine. 17: 206 |
| Yu N, Leung VWY, Meterissian S. (2019) MRI Performance in Detecting pCR After Neoadjuvant Chemotherapy by Molecular Subtype of Breast Cancer. World Journal of Surgery |
| Gruosso T, Gigoux M, Manem VSK, et al. (2019) Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers. The Journal of Clinical Investigation |
| Yip CH, Evans DG, Agarwal G, et al. (2019) Global Disparities in Breast Cancer Genetics Testing, Counselling and Management. World Journal of Surgery |
| Sabiston CM, Wrosch C, Fong AJ, et al. (2018) Life after breast cancer: moving on, sitting down or standing still? A prospective study of Canadian breast cancer survivors. Bmj Open. 8: e021770 |
| Gruosso T, Gigoux M, Bertos N, et al. (2018) Abstract PD6-05: Distinct tumor microenvironments stratify triple negative breast cancer into immune subtypes Cancer Research. 78 |
| Kuasne H, Savage P, Ramirez CM, et al. (2018) Abstract 1044: Establishment and characterization of rare breast patient-derived xenograft models as a potential resource for personalized medicine Cancer Research. 78: 1044-1044 |
| Savage P, Blanchet-Cohen A, Revil T, et al. (2017) A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer. Cell Reports. 21: 1140-1149 |